Research graph
References from Diagnostic performance and cutoff optimisation of the CTD Screen assay for ANA detection compared with HEp-2 IFA. Local targets link to admitted publications; unresolved targets remain external evidence.
International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies
10.1136/annrheumdis-2013-203863 · 2014 · External reference
Detection of antinuclear antibodies by indirect immunofluorescence and by solid phase assay
10.1016/j.autrev.2011.06.005 · 2011 · External reference
Antinuclear Antibody Testing: Gold Standard Revisited
10.1093/jalm/jfab129 · 2022 · External reference
Use of panel testing for detection of antinuclear antibody in a resource-limited setting: an appraisal
10.1080/00325481.2016.1220808 · 2016 · External reference
Clinical Performance of Two Automated Immunoassays, EliA CTD Screen and QUANTA Flash CTD Screen Plus, for Antinuclear Antibody Screening
10.3343/alm.2022.42.1.63 · 2022 · External reference
Performance and clinical evaluation of antinuclear antibody test based on fluorescence enzyme immunoassay
2014 · External reference
Evaluation of an automated connective tissue disease screening assay in Korean patients with systemic rheumatic diseases
10.1371/journal.pone.0173597 · 2017 · External reference
Comparison of the analytical and clinical performances of two different routine testing protocols for antinuclear antibody screening
10.1002/jcla.23914 · 2021 · External reference
Analytical and clinical comparison of two fully automated immunoassay systems for the detection of autoantibodies to extractable nuclear antigens
10.1016/j.cca.2017.11.014 · 2018 · External reference
Diagnosis of Systemic Rheumatic Disease Using the Connective Tissue Disease Screen
10.3390/antib14030056 · 2025 · External reference
The clinical significance of borderline results of the Elia CTD Screen assay
10.1515/cclm-2018-0576 · 2018 · External reference
A comparison of a fluorescence enzyme immunoassay versus indirect immunofluorescence for initial screening of connective tissue diseases: Systematic literature review and meta-analysis of diagnostic test accuracy studies
10.1016/j.berh.2019.03.005 · 2018 · External reference
Clinical performance evaluation of a novel, automated chemiluminescent immunoassay, QUANTA Flash CTD Screen Plus
10.1007/s12026-014-8601-5 · 2014 · External reference
Screening for connective tissue disease-associated antibodies by automated immunoassay
10.1515/cclm-2017-0905 · 2018 · External reference
The association of solid-phase assays to immunofluorescence increases the diagnostic accuracy for ANA screening in patients with autoimmune rheumatic diseases
10.1016/j.autrev.2017.12.007 · 2018 · External reference
Sensitivity of the Phadia EliA connective tissue disease screen for less common disease-specific autoantibodies
10.1136/jcp.2010.084756 · 2011 · External reference
Anti-CENP-A/B reactivity in samples exhibiting the centromere HEp-2 pattern is associated with a lower frequency of interstitial lung disease in limited cutaneous systemic sclerosis patients
10.33393/jcb.2025.3608 · 2025 · External reference
A cell-based assay for detection of anti-fibrillarin autoantibodies with performance equivalent to immunoprecipitation
10.3389/fimmu.2022.1011110 · 2022 · External reference
Comparison of the clinical utility of the Elia CTD Screen to indirect immunofluorescence on Hep-2 cells
10.1515/cclm-2015-1051 · 2015 · External reference
Evaluation of an Automated Screening Assay, Compared to Indirect Immunofluorescence, an Extractable Nuclear Antigen Assay, and a Line Immunoassay in a Large Cohort of Asian Patients with Antinuclear Antibody-Associated Rheumatoid Diseases: A Multicenter Retrospective Study
10.1155/2018/9094217 · 2018 · External reference
Comparison of the analytical and clinical performances of two different routine testing protocols for antinuclear antibody screening
10.1002/jcla.23914 · ExternalCitation · doi-reference
Clinical performance evaluation of a novel, automated chemiluminescent immunoassay, QUANTA Flash CTD Screen Plus
10.1007/s12026-014-8601-5 · ExternalCitation · doi-reference
Detection of antinuclear antibodies by indirect immunofluorescence and by solid phase assay
10.1016/j.autrev.2011.06.005 · ExternalCitation · doi-reference
The association of solid-phase assays to immunofluorescence increases the diagnostic accuracy for ANA screening in patients with autoimmune rheumatic diseases
10.1016/j.autrev.2017.12.007 · ExternalCitation · doi-reference
A comparison of a fluorescence enzyme immunoassay versus indirect immunofluorescence for initial screening of connective tissue diseases: Systematic literature review and meta-analysis of diagnostic test accuracy studies
10.1016/j.berh.2019.03.005 · ExternalCitation · doi-reference
Analytical and clinical comparison of two fully automated immunoassay systems for the detection of autoantibodies to extractable nuclear antigens
10.1016/j.cca.2017.11.014 · ExternalCitation · doi-reference
Use of panel testing for detection of antinuclear antibody in a resource-limited setting: an appraisal
10.1080/00325481.2016.1220808 · ExternalCitation · doi-reference
Antinuclear Antibody Testing: Gold Standard Revisited
10.1093/jalm/jfab129 · ExternalCitation · doi-reference
International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies
10.1136/annrheumdis-2013-203863 · ExternalCitation · doi-reference
Sensitivity of the Phadia EliA connective tissue disease screen for less common disease-specific autoantibodies
10.1136/jcp.2010.084756 · ExternalCitation · doi-reference
Evaluation of an Automated Screening Assay, Compared to Indirect Immunofluorescence, an Extractable Nuclear Antigen Assay, and a Line Immunoassay in a Large Cohort of Asian Patients with Antinuclear Antibody-Associated Rheumatoid Diseases: A Multicenter Retrospective Study
10.1155/2018/9094217 · ExternalCitation · doi-reference
Evaluation of an automated connective tissue disease screening assay in Korean patients with systemic rheumatic diseases
10.1371/journal.pone.0173597 · ExternalCitation · doi-reference
Comparison of the clinical utility of the Elia CTD Screen to indirect immunofluorescence on Hep-2 cells
10.1515/cclm-2015-1051 · ExternalCitation · doi-reference
Screening for connective tissue disease-associated antibodies by automated immunoassay
10.1515/cclm-2017-0905 · ExternalCitation · doi-reference
The clinical significance of borderline results of the Elia CTD Screen assay
10.1515/cclm-2018-0576 · ExternalCitation · doi-reference
Anti-CENP-A/B reactivity in samples exhibiting the centromere HEp-2 pattern is associated with a lower frequency of interstitial lung disease in limited cutaneous systemic sclerosis patients
10.33393/jcb.2025.3608 · ExternalCitation · doi-reference
Clinical Performance of Two Automated Immunoassays, EliA CTD Screen and QUANTA Flash CTD Screen Plus, for Antinuclear Antibody Screening
10.3343/alm.2022.42.1.63 · ExternalCitation · doi-reference
A cell-based assay for detection of anti-fibrillarin autoantibodies with performance equivalent to immunoprecipitation
10.3389/fimmu.2022.1011110 · ExternalCitation · doi-reference
Diagnosis of Systemic Rheumatic Disease Using the Connective Tissue Disease Screen
10.3390/antib14030056 · ExternalCitation · doi-reference
